Aliyah Sohani, MD
Aliyah Sohani, MD
Director of Surgical Pathology, Massachusetts General Hospital
Associate Professor of Pathology, Harvard Medical School
Departments, Centers, & Programs:
55 Fruit Street
Boston, MA 02114-2696
- MD, Harvard Medical School
- Residency, Massachusetts General Hospital
- Fellowship, Massachusetts General Hospital
American Board Certifications
- Hematopathology, American Board of Pathology
- Anatomic Pathology & Clinical Pathology, American Board of Pathology
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Sohani's major research interest is in the identification of novel pathologic, immunophenotypic and molecular markers in lymphoma that may help to define new clinicopathologic entities and predict tumor behavior and response to therapy. These efforts have led to the contribution of new knowledge and several key innovations to the field of lymphoma diagnosis and classification, including the first description of unusual, non-neoplastic T-cell populations in nodular lymphocyte predominant Hodgkin lymphoma; improved methods of screening for and diagnosing aggressive high-grade B-cell lymphomas with MYC and BCL2 rearrangements (double-hit lymphoma); improved diagnostic guidelines related to recognition by pathologists of rare cases of extranodal NK/T-cell lymphoma with deceptively bland cytomorphology; immunophenotypic and genetic evidence supporting the distinct pathogenesis of EBV-negative vs. EBV+ monomorphic post-transplant lymphoproliferative disorder; and development of an immunohistochemistry-based biologic risk score in primary mediastinal large B-cell lymphoma. In addition to her research interests in lymphoma, Dr. Sohani is involved in developing guidelines for lymphoma diagnosis and prognosis in regions of the world with limited testing resources and exploring ways that telemedicine and web-based learning can be used to enhance the delivery of pathology services in resource-limited settings and provide educational support to pathologists practicing in low/middle-income countries.